ONCOLYTICS BIOTECH INC
Oncolytics Biotech is dedicated to enhancing the lives of cancer patients through the development of pelareorep, a unique immunotherapy that activates the immune system to target and destroy cancer cells. The systemic delivery of pelareorep sets it apart from other treatments, offering broad potential in various cancer indications. Through collaborations with academic and pharmaceutical partners, Oncolytics Biotech aims to revolutionize cancer treatment and improve patient outcomes.
Welcome to our business profile
Here are a few images about us. Please visit our website for more
